Aviva’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Aviva’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-23,981	Closed	-$1.72M	–	1086
2022 Q2	$1.72M	Sell	23,981 -6,868	-22%	-$502K	0.01%	902
2022 Q1	$2.5M	Hold	30,849	–	–	0.01%	745
2021 Q4	$3.17M	Sell	30,849 -2,027	-6%	-$195K	0.01%	686
2021 Q3	$2.88M	Buy	32,876 +6,171	+23%	+$559K	0.01%	696
2021 Q2	$2.39M	Buy	26,705 +7,830	+41%	+$662K	0.01%	738
2021 Q1	$1.43M	Buy	+18,875	New	+$1.42M	0.01%	727

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.84B AUM 6.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Aviva's SYNH Position: Q3 2022 in Review

Aviva sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2022, closing a stake of 23,981 shares — an estimated $1.72M sold.

Aviva first reported a position in SYNH in Q1 2021 and held it in 6 quarters. The position peaked at $3.17M in Q4 2021. 337 funds tracked by Wall St. Rank hold SYNH as of Q3 2022.

Aviva reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2022 after selling out during the quarter.
Aviva sold 23,981 Syneos Health, Inc. Class A Common Stock shares in Q3 2022, an estimated $1.72M.
Aviva first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2021 and held it in 6 quarters.
Aviva's Syneos Health, Inc. Class A Common Stock position peaked at $3.17M in Q4 2021.
337 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2022.

Based on Aviva's 13F filing for Q3 2022, filed 14 Nov 2022.